SIA
RMD icon

SGL Investment Advisors’s ResMed RMD Stock Holding History

SGL Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Sell
10,409
-838
-7% -$174K 0.79% 38
2026
Q1 		$2.24M Sell
11,247
-79
-0.7% -$19.7K 0.84% 39
2025
Q4 		$3.02M Buy
11,326
+27
+0.2% +$6.91K 1.21% 30
2025
Q3 		$2.81M Buy
11,299
+229
+2% +$62.6K 1.17% 31
2025
Q2 		$2.84M Sell
11,070
-1,461
-12% -$349K 1.35% 32
2025
Q1 		$3.05M Buy
+12,531
New +$2.93M 1.57% 30

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SGL Investment Advisors's RMD Position: Q2 2026 in Review

SGL Investment Advisors reduced its ResMed (RMD) stake by 7.5% in Q2 2026, selling an estimated $174K and leaving 10,409 shares worth $2.29M. The position accounts for 0.79% of the portfolio, ranked #38.

SGL Investment Advisors first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.05M in Q1 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SGL Investment Advisors held 10,409 shares of ResMed worth $2.29M as of Q2 2026.
  • SGL Investment Advisors sold 838 ResMed shares in Q2 2026, an estimated $174K.
  • ResMed made up 0.79% of SGL Investment Advisors's portfolio in Q2 2026, its #38 holding.
  • SGL Investment Advisors first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • SGL Investment Advisors's ResMed position peaked at $3.05M in Q1 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.